Connection

CHAD CREIGHTON to RNA, Neoplasm

This is a "connection" page, showing publications CHAD CREIGHTON has written about RNA, Neoplasm.
Connection Strength

0.514
  1. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. J Clin Invest. 2018 04 02; 128(4):1267-1282.
    View in: PubMed
    Score: 0.138
  2. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 04; 499(7456):43-9.
    View in: PubMed
    Score: 0.100
  3. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 04; 490(7418):61-70.
    View in: PubMed
    Score: 0.095
  4. Addiction to Golgi-resident PI4P synthesis in chromosome 1q21.3-amplified lung adenocarcinoma cells. Proc Natl Acad Sci U S A. 2021 06 22; 118(25).
    View in: PubMed
    Score: 0.043
  5. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression. Cancer Res. 2020 09 15; 80(18):3810-3819.
    View in: PubMed
    Score: 0.041
  6. MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019 02; 79(3):265-271.
    View in: PubMed
    Score: 0.036
  7. Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11. J Clin Invest. 2017 01 03; 127(1):117-131.
    View in: PubMed
    Score: 0.032
  8. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14; 374(2):135-45.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.